Atrás
20
También listada como
MCARY
OTC
Rango del Día
$15.88
$22.05
Rango de 52 Semanas
$15.88
$22.05
Volumen
200
Promedio 50D / 200D
$15.88
/
$16.01
Cierre Anterior
$15.88
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Consumer Cyclical (610 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 0.1 | 11.1 |
| P/B | 0.0 | 1.4 |
| ROE % | 30.5 | 10.7 |
| Net Margin % | 13.6 | 5.1 |
| Rev Growth 5Y % | 16.1 | 8.3 |
| D/E | 2.0 | 0.8 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$266.77
$252.96 – $285.09
|
320 B | 1 |
| FY2029 |
$225.19
$213.53 – $240.65
|
280 B | 1 |
| FY2028 |
$210.77
$199.85 – $225.24
|
250 B | 1 |
Puntos Clave
Revenue grew 16.07% annually over 5 years — strong growth
Earnings grew 94.00% over the past year
ROE of 30.52% indicates high profitability
Debt/Equity of 2.01 — high leverage
Negative free cash flow of -12.25B
P/E of 0.10 — trading at a low valuation
Crecimiento
Revenue Growth (5Y)
16.07%
Revenue (1Y)2.79%
Earnings (1Y)94.00%
FCF Growth (3Y)N/A
Calidad
Return on Equity
30.52%
ROIC6.99%
Net Margin13.56%
Op. Margin14.45%
Seguridad
Debt / Equity
2.01
Current Ratio1.32
Interest Coverage41.68
Valoración
P/E Ratio
0.10
P/B Ratio0.03
EV/EBITDA1.75
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.79% | Revenue Growth (3Y) | 5.81% |
| Earnings Growth (1Y) | 94.00% | Earnings Growth (3Y) | 41.35% |
| Revenue Growth (5Y) | 16.07% | Earnings Growth (5Y) | 46.17% |
| Profitability | |||
| Revenue (TTM) | 192.63B | Net Income (TTM) | 26.11B |
| ROE | 30.52% | ROA | 4.80% |
| Gross Margin | 71.77% | Operating Margin | 14.45% |
| Net Margin | 13.56% | Free Cash Flow (TTM) | -12.25B |
| ROIC | 6.99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2.01 | Current Ratio | 1.32 |
| Interest Coverage | 41.68 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 0.10 | P/B Ratio | 0.03 |
| P/S Ratio | 0.01 | PEG Ratio | 0.17 |
| EV/EBITDA | 1.75 | Dividend Yield | 0.00% |
| Market Cap | 2.62B | Enterprise Value | 48.60B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 192.63B | 187.41B | 172.06B | 147.05B | 106.12B |
| Net Income | 26.11B | 13.46B | 13.07B | -7.57B | 5.72B |
| EPS (Diluted) | 154.85 | 79.01 | 77.36 | -47.33 | 35.15 |
| Gross Profit | 138.26B | 129.73B | 114.43B | 95.14B | 81.80B |
| Operating Income | 27.84B | 18.87B | 17.06B | -3.72B | 5.18B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 543.76B | 501.77B | 415.35B | 339.86B | 262.53B |
| Total Liabilities | 444.12B | 429.63B | 360.12B | 301.87B | 222.52B |
| Shareholders' Equity | 99.27B | 71.84B | 54.67B | 37.68B | 39.63B |
| Total Debt | 199.38B | 193.31B | 158.00B | 131.35B | 71.15B |
| Cash & Equivalents | 153.40B | 192.00B | 204.53B | 211.41B | 171.46B |
| Current Assets | 420.24B | 402.03B | 340.64B | 303.40B | 227.93B |
| Current Liabilities | 319.51B | 302.54B | 273.61B | 224.72B | 205.33B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#411 of 658
Actividad Reciente
Entró
Contrarian Investing (David Dreman)
Mar 24, 2026